Novo Nordisk is today hosting a Capital Markets Day (CMD) where the company is providing a progress update on its Strategic Aspirations 2025. The Strategic Aspirations 2025 were introduced in...
(“Chunghwa” or “the Company) today announced that its Board of Directors (the “Board”) resolved to raise up to NT$10 billion of unsecured corporate bonds in Taiwan. The proceeds will be used to finance...